Category Archives: Spinal Cord Injury Treatment

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on San Antonio’s Fox News First on KABB-TV on Wednesday, February 22nd during their 7:00 AM (CST) newscast. Reynolds is also scheduled to appear the same day on San Antonio Living on WOAI-TV that airs from 10:00 to 11:00 AM (CST). InVivo Therapeutics has pioneered a new treatment platform that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovery and prognosis after a traumatic spinal cord injury. Reynolds will discuss the scaffold and how it is expected to work in humans, as well as results from InVivo’s largest non-human primate study. “We expect that our technology will change the standard care for spinal cord injury treatment. We’re currently under review at FDA and we look forward to receiving approval to begin human studies,” said Reynolds. “Our therapeutic approach confirms a clear paradigm shift in the treatment of spinal cord injuries.” Fox News First is the morning show that airs weekdays from 5:00 – … Continue reading →

Assessing and developing treatment for spinal cord injuries has long proved difficult for scientists hampered by a lack of available tools and imaging techniques. Now however, a team of Cornell researchers has developed a method to potentially circumvent this problem by surgically implanting a window into the spinal cord of a mouse, allowing for dynamic and long term imaging at a cellular level. In an article published in the January issue of Nature Methods, Prof. Chris Schaffer, biomedical engineering, and Matthew Farrar grad designed and inserted a chamber into the backs of mice that enables researchers to view of the cellular interactions in spinal cord injury sites. Working alongside Prof. Joseph Fetcho, neurobiology and behavior, Schaffer and Farrar aimed at identifying ways that researchers could advance the quality of spinal cord injury treatment by developing an improved imaging procedure. The previous method for observing cells after spinal cord injury was to perform multiple surgeries to image the damaged site. However, according to Farrar, multiple surgeries are harmful to the mice because researchers must repeatedly reopen the skin and risk causing inflammation, increasing the risk of infection and the growth of fibrotic tissue. This makes carrying out multiple surgeries a less … Continue reading →

ROCKVILLE, Md., Feb. 14, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced today that it has closed on its previously announced registered direct placement of 5,200,000 shares of common stock at a price of $1.00 per share, and 5,200,000 warrants each with an exercise price of $1.02 per share and exercisable starting six months from the issuance date for a term of five years. The company received aggregate gross proceeds of $5,200,000, which will be used for general corporate purposes, including ongoing U.S. clinical trials. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) T.R. Winston & Company, LLC acted as the exclusive placement agent for the offering. About Neuralstem Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is in an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease, and has been awarded orphan status designation by the FDA. In addition to ALS, the company is also targeting major central nervous system conditions with its cell therapy platform, including spinal cord injury, … Continue reading →

MENLO PARK, Calif.--(BUSINESS WIRE)-- Velomedix, Inc., a clinical stage medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to evaluate the use of rapid therapeutic hypothermia for the treatment of patients suffering an acute myocardial infarction (AMI or heart attack). The conditional approval allows the company to initiate a clinical trial at select sites in the United States. Therapeutic hypothermia has been shown to significantly improve outcomes for several acute events such as cardiac arrest, heart attack, and acute ischemic stroke. It has also been used with great success for spinal cord injury. While there are several technologies currently being marketed for hypothermia management, Velomedix’s proprietary technology delivers unparalleled cooling speed and procedural efficiency that is expected to result in enhanced clinical outcomes and enable more widespread clinical adoption of this promising therapy. “While current technologies can reach a therapeutic target temperature of 33C in 1-2 hours, the Velomedix system has shown the ability to achieve 33C in less than 15 minutes,” commented Jeff Gold, President and CEO of Velomedix. “For AMI patients requiring an intervention to open a blocked artery, the ability … Continue reading →

01-02-2012 16:34 Spinal cord injury treatment. http://www.projectwalk.org exists to provide an improved quality of life for people with spinal cord injuries through intense exercise-based recovery programs, education, support and encouragement. More: "Kyle Eade, "Project Walk Spinal Cord Injury Recovery" - Video … Continue reading →

23-01-2012 15:42 Spinal cord injury treatment. http://www.projectwalk.org exists to provide an improved quality of life for people with spinal cord injuries through intense exercise-based recovery programs, education, support and encouragement. Read the original here: "Trevor Comeau,"Project Walk Spinal Cord Injury Recovery" - Video … Continue reading →

02-01-2012 18:36 Spinal cord injury treatment. http://www.projectwalk.org exists to provide an improved quality of life for people with spinal cord injuries through intense exercise-based recovery programs, education, support and encouragement. See the original post: "Joe Guintu", "Project Walk Spinal Cord Injury Recovery" - Video … Continue reading →

06-01-2012 12:16 Spinal cord injury treatment. http://www.projectwalk.org exists to provide an improved quality of life for people with spinal cord injuries through intense exercise-based recovery programs, education, support and encouragement. Go here to see the original: "Annette Ross", "Project Walk Spinal Cord Injury Recovery" - Video … Continue reading →

11-01-2012 14:02 Spinal cord injury treatment. http://www.projectwalk.org exists to provide an improved quality of life for people with spinal cord injuries through intense exercise-based recovery programs, education, support and encouragement. Read more: "Nathan Bayer", "Project Walk Spinal Cord Injury Recovery" - Video … Continue reading →

06-01-2012 12:28 Spinal cord injury treatment. http://www.projectwalk.org exists to provide an improved quality of life for people with spinal cord injuries through intense exercise-based recovery programs, education, support and encouragement. See more here: "Ashley Vargas", "Project Walk Spinal Cord Injury Recovery" - Video … Continue reading →